rasagiline has been researched along with Dyskinesia, Drug-Induced in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amboni, M; Barone, P; Bombieri, F; Di Matteo, A; Fasano, A; Ferigo, L; Santangelo, G; Squintani, G; Tinazzi, M; Vitale, C | 1 |
| Jankovic, J; Olanow, CW | 1 |
1 review(s) available for rasagiline and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Coenzymes; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Indans; Levodopa; Membrane Proteins; N-Methylaspartate; Neuroprotective Agents; Parkinson Disease; Prostaglandin-Endoperoxide Synthases; Ubiquinone; Vitamin E | 2005 |
1 other study(ies) available for rasagiline and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy.
Topics: Aged; Dopamine Agents; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease | 2011 |